Cardizef

Dongkwang Pharm. Co., Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Id: 51bd0af44e79c1f3
Drug Approval Philippines Name: Cardizef
Product Name: Cardizef
Registration Number: DRP-8014-07
Brand Name: Cardizef
Generic Name: Nicardipine Hydrochloride
Dosage Form: Solution For Injection (Iv)
Dosage Strength: 10mg/10mL (1mg/1mL)
Manufacturer: Dongkwang Pharm. Co., Ltd.
Importer: JLT Pharma, Inc.
Distributor: Metro Pharma Philippines Inc.
Company Detail Path: /organization/dongkwang-pharm-co-ltd
Issuance Date: 25 May 2022
Expiry Date: 17 August 2027
Pharmacologic Category: Dihydropyridine derivatives (Selective Calcium Channel Blockers with mainly vascular effects)
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

51bd0af44e79c1f3

Type

Standard